BPOM Achieves WHO Listed Authority Status, Strengthens Indonesia's Health Diplomacy

Jakarta — By the end of 2025, Indonesia’s Drug and Food Supervisory Agency (BPOM) has made history by being recognised as a WHO Listed Authority (WLA). This means BPOM’s drug and food surveillance system adheres to international standards equivalent to those of developed nations’ regulatory authorities, thereby enhancing its reputation.

BPOM Head Taruna Ikrar stated that the agency’s achievement of WLA status resulted from collective effort across all BPOM divisions in meeting nine drug and food surveillance assessment criteria.

The criteria successfully fulfilled by BPOM include: regulatory systems and governance; licensing and marketing authorisation; drug surveillance and pharmacovigilance; surveillance aspects; clinical trial oversight for drugs and vaccines; quality and accuracy of regulatory laboratories; certification issuance oversight; production inspection standards for drugs and food; and surveillance of drug and vaccine distribution.

BPOM’s achievement of WLA level represents an opportunity for Indonesia to produce health and food products with strong reputations, as they would be overseen by a globally recognised authority.

The nine criteria BPOM successfully met encompass comprehensive regulatory frameworks, from initial product licensing through post-market surveillance and distribution monitoring, positioning the agency as a trusted regulator on the international stage.